-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
GSK-364735
Category | Human immunodeficiency Virus (HIV) |
CAS | 863434-13-3 |
Product Information
Synonyms | GSK-364735;GSK364735;SXN0KXT60S;863434-13-3;UNII-SXN0KXT60S;1,5-Naphthyridine-3-carboxamide, 7-((4-fluorophenyl)methyl)-1,2-dihydro-4-hydroxy-N-(2-hydroxyethyl)-1-methyl-2-oxo-;CHEMBL1256978;S-364735;7-[(4-fluorophenyl)methyl]-4-hydroxy-N-(2-hydroxyethyl)-1-methyl-2-oxo-1,5-naphthyridine-3-carboxamide;7-((4-FLUOROPHENYL)METHYL)-4-HYDROXY-N-(2-HYDROXYETHYL)-1-METHYL-2-OXO-1,5-NAPHTHYRIDINE-3-CARBOXAMIDE;SCHEMBL5545304;QWLNINWUBHHOLU-UHFFFAOYSA-N;BDBM50045107;S/GSK 364735;S/GSK-364735;DB13119;NS00073316;Q27289447;7-[(4-fluorophenyl)methyl]-4-hydroxy-N-(2-hydroxyethyl)-1-methyl-2-oxo-1,2-dihydro-1,5-naphthyridine-3-carboxamide; |
IUPAC Name | 7-[(4-fluorophenyl)methyl]-4-hydroxy-N-(2-hydroxyethyl)-1-methyl-2-oxo-1,5-naphthyridine-3-carboxamide |
Molecular Weight | 843.9 |
Molecular Formula | C38H48F3N11O8 |
Canonical SMILES | C1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC2=CC3=CC=CC=C3C=C2)CCCN=C(N)N)CCCN=C(N)N)CC4=CC=C(C=C4)O.C(=O)(C(F)(F)F)O |
InChI | InChI=1S/C19H18FN3O4/c1-23-14-9-12(8-11-2-4-13(20)5-3-11)10-22-16(14)17(25)15(19(23)27)18(26)21-6-7-24/h2-5,9-10,24-25H,6-8H2,1H3,(H,21,26) |
InChIKey | QWLNINWUBHHOLU-UHFFFAOYSA-N |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |